Clinical Trial: A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thyroid Cancer
Study Type: OBSERVATIONAL
Official Title: Outcomes of Patients With Thyroid Carcinoma Treated With Redifferentiating Agents as Part of Routine Clinical Care: A Prospective Data Collection Study
Brief Summary:
The purpose of this study to learn more about the use of redifferentiating medications as a standard treatment for radioactive iodine/RAI-refractory thyroid cancer.This study is a registry study.
Read more